Showing 111-120 of 20874 results for "".
The CELMoD Shift: Translating Protein Degradation Science Into Practice-Changing Myeloma Care
https://reachmd.com/live-events/the-celmod-shift-translating-protein-degradation-science-into-practice-changing-myeloma-care/67114/Join us for lunch and explore how CELMoDs are reshaping myeloma care with expert discussion of pivotal data & practical strategies for integrating them into the treatment paradigm.Location: OnlineDate: December 11, 2026; 12:00 PM - 01:30 PM CTAdvancing Acromegaly Care: Diving Deeper Into Diagnosis, Guideline Application, and Emerging Therapies—A Fireside Chat With Expert Perspectives
https://reachmd.com/live-events/advancing-acromegaly-care-diving-deeper-into-diagnosis-guideline-application-and-emerging-therapiesa-fireside-chat-with-expert-perspectives/56308/Explore diagnostic strategies, guideline-based therapy selection, and emerging options for individualized management of patients with acromegaly.Location: Chicago, Illinois, United StatesDate: June 15, 2027; 06:00 AM - 08:00 AM ETAdvancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
https://reachmd.com/live-events/advancing-treat-to-target-care-in-generalized-myasthenia-gravis-earlier-diagnosis-standardized-assessment-and-precision-use-of-fcrn-directed-therapy/56668/Through live expert discussion, examine gMG diagnosis, standardized assessment, treat-to-target care, and the integration of FcRn-directed therapy.Location: New York, New York, United StatesDate: October 10, 2026; 05:00 PM - 07:00 PM ETAdvancing Precision Diagnosis and Treatment Strategies in Acromegaly: A Q-Challenge Live Clinical Decision Experience
https://reachmd.com/live-events/advancing-precision-diagnosis-and-treatment-strategies-in-acromegaly-a-q-challenge-live-clinical-decision-experience/54480/Apply diagnostic and treatment strategies for acromegaly using interactive, case-based Q-Challenge scenarios at AACE 2026.Location: OnlineDate: April 23, 2026; 06:00 PM - 07:30 PM PTRedefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
https://reachmd.com/live-events/redefining-gmg-management-fcrn-antagonists-and-the-new-era-of-precision-neurology/45567/Join us for lunch as experts examine guidelines, pathophysiology-based care, and integration of emerging FcRn therapies for generalized myasthenia gravis.Location: Orlando, Florida, United StatesDate: September 30, 2026; 11:45 AM - 12:45 PM ETRedefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
https://reachmd.com/live-events/redefining-gmg-management-fcrn-antagonists-and-the-new-era-of-precision-neurology/56712/Join us for lunch as experts examine guidelines, pathophysiology-based care, and integration of emerging FcRn therapies for generalized myasthenia gravis.Location: OnlineDate: September 30, 2026; 11:45 AM - 12:45 PM ETRedefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
https://reachmd.com/live-events/redefining-gmg-management-fcrn-antagonists-and-the-new-era-of-precision-neurology/56711/Join us for lunch as experts examine guidelines, pathophysiology-based care, and integration of emerging FcRn therapies for generalized myasthenia gravis.Location: Orlando, Florida, United StatesDate: September 30, 2026; 11:45 AM - 12:45 PM ETClosing the Gap in First-Line Treatment of KRAS G12C–Mutated Advanced NSCLC: From Biology to Bedside Decisions and Trial-Ready Care
https://reachmd.com/live-events/closing-the-gap-in-first-line-treatment-of-kras-g12cmutated-advanced-nsclc-from-biology-to-bedside-decisions-and-trial-ready-care/57275/Improve first-line care for KRAS G12C–mutated advanced NSCLC through timely biomarker testing, personalized treatment strategy, and clinical trial referral.Location: OnlineDate: September 22, 2026; 06:00 PM - 06:45 PM EDTAdvancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
https://reachmd.com/live-events/advancing-treat-to-target-care-in-generalized-myasthenia-gravis-earlier-diagnosis-standardized-assessment-and-precision-use-of-fcrn-directed-therapy/56565/Through live expert discussion, examine gMG diagnosis, standardized assessment, treat-to-target care, and the integration of FcRn-directed therapy.Location: Palo Alto, California, United StatesDate: September 18, 2026; 06:30 PM - 08:30 PM PTFrom Fragmented Symptoms to Structured Care: Advancing Menopause Management in Primary Practice
https://reachmd.com/live-events/from-fragmented-symptoms-to-structured-care-advancing-menopause-management-in-primary-practice/67380/Join us for dinner and explore menopause care with this AI-assisted (Clara®), case-based learning activity designed to support clinical reasoning and informed decision-making.Location: OnlineDate: October 19, 2026; 07:00 PM - 08:00 PM CT